VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,261,557 | -42.0% | 132,962 | -45.0% | 0.00% | -33.3% |
| Q1 2023 | $5,620,868 | -15.4% | 241,550 | -8.0% | 0.01% | -25.0% |
| Q4 2022 | $6,642,660 | +134.4% | 262,452 | +78.5% | 0.01% | +100.0% |
| Q3 2022 | $2,834,000 | +425.8% | 146,993 | +594.2% | 0.00% | +300.0% |
| Q2 2022 | $539,000 | -74.7% | 21,174 | -74.4% | 0.00% | -50.0% |
| Q1 2022 | $2,127,000 | +189.4% | 82,710 | +371.1% | 0.00% | +100.0% |
| Q4 2021 | $735,000 | -66.5% | 17,558 | -65.1% | 0.00% | -50.0% |
| Q3 2021 | $2,192,000 | -51.6% | 50,372 | -47.4% | 0.00% | -60.0% |
| Q2 2021 | $4,528,000 | – | 95,767 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |